generalize

(redirected from generalised)
Also found in: Dictionary, Thesaurus, Legal, Encyclopedia, Wikipedia.
Related to generalised: Generalised anxiety disorder

generalize

/gen·er·al·ize/ (-ĭz)
1. to spread throughout the body, as when local disease becomes systemic.
2. to form a general principle; to reason inductively.

generalize

(jĕn′ər-ə-līz′)
v. general·ized, general·izing, general·izes
v.tr.
1.
a. To reduce to a general form, class, or law.
b. To render indefinite or unspecific.
2.
a. To infer from many particulars.
b. To draw inferences or a general conclusion from.
v.intr.
1.
a. To form a concept inductively.
b. To form general notions or conclusions.
2. Medicine To spread through the body. Used of a usually localized disease.

gen′er·al·iz′a·ble adj.
gen′er·al·iz′er n.

generalize

(jen′ĕ-ră-līz″) [L. generalis]
1. To become or render nonspecific.
2. To become systemic, as a local disease.
generalizable (jen″ĕ-ră-lī′ză-bl), adjectivegeneralizability (jen″ĕ-ră-lī″ză-bil′ĭt-ē)
References in periodicals archive ?
Findings from this pooled analysis of Phase III data provide an important look into the efficacy and tolerability of perampanel in people with primary and secondary generalised tonic clonic seizures.
Ahsanullah, The generalised order statistics from exponential distribution, Pak.
Duloxetine is approved for the treatment of depression and diabetic peripheral neuropathic pain in many countries and also approved in some countries for the treatment of stress urinary incontinence, fibromyalgia, major depressive disorder and generalised anxiety disorder.
There are approximately 496, 920 people in Russia with epilepsy; one third of these have idiopathic generalised epilepsy and approximately 60% of these (103,525 people), will experience PGTC seizures.
average, patients treated with duloxetine for generalised anxiety disorder
Perampanel, an oral treatment with a simple titration regimen, is currently indicated for the adjunctive treatment of partial-onset seizures with or without secondarily generalised seizures in patients from 12 years of age with epilepsy, and as adjunctive therapy for the treatment of primary generalised tonic-clonic seizures in patients aged 12 years and older with idioipathic generalised epilepsy.
Despite treatment, around 20% of people with idiopathic generalised epilepsy remain uncontrolled.
The launch of perampanel in the UK for refractory generalised convulsions is welcome news for people living with this type of seizure.
Using a Fycompa-based treatment regime will give physicians another treatment option for primary generalised tonic-clonic seizures, to ensure the best quality of life is achieved at the earliest opportunity.
perampanel) today received positive opinion for use as a once-daily, adjunctive therapy for primary generalised tonic-clonic seizures in adult and adolescent patients from 12 years of age with idiopathic generalised epilepsy from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP).
Food and Drug Administration (FDA) has approved the antidepressant Cymbalta(R) (duloxetine HCl) for the treatment of generalised anxiety disorder (GAD), Eli Lilly and Company (NYSE: LLY) and Boehringer Ingelheim announced today.

Full browser ?